Mucosal and Systemic Antibody Responses After Boosting With a Bivalent Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine.
Saved in:
| Title: | Mucosal and Systemic Antibody Responses After Boosting With a Bivalent Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine. |
|---|---|
| Authors: | Atmar RL; Departments of Medicine and Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA., Lyke KE; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA., Posavad CM; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Deming ME; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA., Brady RC; Cincinnati Children's Hospital Medical Center, Division of Infectious Diseases, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA., Dobrzynski D; Division of Infectious Diseases, Department of Medicine, University of Rochester, Rochester, New York, USA., Edupuganti S; Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA., Mulligan MJ; New York University Langone Vaccine Center and Division of Infectious Diseases and Immunology, Department of Medicine, New York University Grossman School of Medicine, New York, New York, USA., Rupp RE; Sealy Institute for Vaccine Sciences, University of Texas Medical Branch, Galveston, Texas, USA., Rostad CA; Department of Pediatrics and Center for Childhood Infections and Vaccines, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, Georgia, USA., Jackson LA; Kaiser Permanente Washington Health Research Institute, Seattle, Washington, USA., Martin JM; Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA., Shriver MC; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA., Rajakumar K; Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA., Coler RN; Seattle Children's Research Institute, Seattle, Washington, USA.; Department of Pediatrics, University of Washington School of Medicine, Seattle, Washington, USA., El Sahly HM; Departments of Medicine and Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA., Kottkamp AC; New York University Langone Vaccine Center and Division of Infectious Diseases and Immunology, Department of Medicine, New York University Grossman School of Medicine, New York, New York, USA., Branche AR; Division of Infectious Diseases, Department of Medicine, University of Rochester, Rochester, New York, USA., Frenck RW; Cincinnati Children's Hospital Medical Center, Division of Infectious Diseases, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA., Johnston C; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; Department of Medicine, University of Washington School of Medicine, Seattle, Washington, USA., Babu TM; Department of Medicine, University of Washington School of Medicine, Seattle, Washington, USA., Bäcker M; New York University Langone Hospital-Long Island Vaccine Center Research Clinic and Division of Infectious Disease, Department of Medicine, New York University Grossman Long Island School of Medicine, Mineola, New York, USA., Archer JI; FHI, Durham, North Carolina, USA., Crandon S; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Nakamura A; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Nayak SU; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Szydlo D; Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Dominguez Islas CP; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Brown ER; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., O'Connell SE; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Montefiori DC; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, USA.; Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA., Eaton A; Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA., Neuzil KM; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA., Stephens DS; Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA., Beigel JH; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Pasetti M; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA., Roberts PC; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA. |
| Source: | The Journal of infectious diseases [J Infect Dis] 2025 Oct 15; Vol. 232 (4), pp. 971-981. |
| Publication Type: | Journal Article; Clinical Trial, Phase I; Clinical Trial, Phase II |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
